Nuclear Factor–Erythroid-2–Related Factor 2 in Aging and Lung Fibrosis

American Journal of Pathology

Volumn 186, Issue 7, 2016, Pages 1712-1723

  Swamy, Shobha M ^a   Rajasekaran, Namakkal S ^a   Thannickal, Victor J ^a  

^a UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

KELCH LIKE ECH ASSOCIATED PROTEIN 1; TRANSCRIPTION FACTOR NRF2;

AGING; GENETIC TRANSCRIPTION; HOMEOSTASIS; HUMAN; LUNG FIBROSIS; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN TARGETING; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; METABOLISM; PHYSIOLOGY;

AGING; ANIMALS; HOMEOSTASIS; HUMANS; NF-E2-RELATED FACTOR 2; PULMONARY FIBROSIS; SIGNAL TRANSDUCTION;

EID: 84997503530     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2016.02.022     Document Type: Review

References (135)

1. 1 Thannickal, V.J., Murthy, M., Balch, W.E., Chandel, N.S., Meiners, S., Eickelberg, O., Selman, M., Pardo, A., White, E.S., Levy, B.D., Busse, P.J., Tuder, R.M., Antony, V.B., Sznajder, J.I., Budinger, G.R., Blue journal conference: aging and susceptibility to lung disease. Am J Respir Crit Care Med 191 (2015), 261–269.
2. 2 Hecker, L., Logsdon, N.J., Kurundkar, D., Kurundkar, A., Bernard, K., Hock, T., Meldrum, E., Sanders, Y.Y., Thannickal, V.J., Reversal of persistent fibrosis in aging by targeting Nox4-Nrf2 redox imbalance. Sci Transl Med, 6, 2014, 231ra247.
3. 3 Al-Sawaf, O., Clarner, T., Fragoulis, A., Kan, Y.W., Pufe, T., Streetz, K., Wruck, C.J., Nrf2 in health and disease: current and future clinical implications. Clin Sci (Lond) 129 (2015), 989–999.
4. 4 Jaramillo, M.C., Zhang, D.D., The emerging role of the Nrf2-Keap1 signaling pathway in cancer. Genes Dev 27 (2013), 2179–2191.
5. 5 Zhang, D.D., Lo, S.C., Cross, J.V., Templeton, D.J., Hannink, M., Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex. Mol Cell Biol 24 (2004), 10941–10953.
6. 6 McMahon, M., Thomas, N., Itoh, K., Yamamoto, M., Hayes, J.D., Dimerization of substrate adaptors can facilitate cullin-mediated ubiquitylation of proteins by a “tethering” mechanism: a two-site interaction model for the Nrf2-Keap1 complex. J Biol Chem 281 (2006), 24756–24768.
7. 7 Nioi, P., Nguyen, T., Sherratt, P.J., Pickett, C.B., The carboxy-terminal Neh3 domain of Nrf2 is required for transcriptional activation. Mol Cell Biol 25 (2005), 10895–10906.
8. 8 Katoh, Y., Itoh, K., Yoshida, E., Miyagishi, M., Fukamizu, A., Yamamoto, M., Two domains of Nrf2 cooperatively bind CBP, a CREB binding protein, and synergistically activate transcription. Genes Cells 6 (2001), 857–868.
9. 9 Moi, P., Chan, K., Asunis, I., Cao, A., Kan, Y.W., Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2/AP1 repeat of the beta-globin locus control region. Proc Natl Acad Sci U S A 91 (1994), 9926–9930.
10. 10 McMahon, M., Thomas, N., Itoh, K., Yamamoto, M., Hayes, J.D., Redox-regulated turnover of Nrf2 is determined by at least two separate protein domains, the redox-sensitive Neh2 degron and the redox-insensitive Neh6 degron. J Biol Chem 279 (2004), 31556–31567.
11. 11 Wang, H., Liu, K., Geng, M., Gao, P., Wu, X., Hai, Y., Li, Y., Luo, L., Hayes, J.D., Wang, X.J., Tang, X., RXRalpha inhibits the NRF2-ARE signaling pathway through a direct interaction with the Neh7 domain of NRF2. Cancer Res 73 (2013), 3097–3108.
12. 12 Dhakshinamoorthy, S., Jaiswal, A.K., Functional characterization and role of INrf2 in antioxidant response element-mediated expression and antioxidant induction of NAD(P)H:quinone oxidoreductase1 gene. Oncogene 20 (2001), 3906–3917.
13. 13 Ogura, T., Tong, K.I., Mio, K., Maruyama, Y., Kurokawa, H., Sato, C., Yamamoto, M., Keap1 is a forked-stem dimer structure with two large spheres enclosing the intervening, double glycine repeat, and C-terminal domains. Proc Natl Acad Sci U S A 107 (2010), 2842–2847.
14. 14 Zhang, D.D., Hannink, M., Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress. Mol Cell Biol 23 (2003), 8137–8151.
15. 15 Niture, S.K., Jain, A.K., Jaiswal, A.K., Antioxidant-induced modification of INrf2 cysteine 151 and PKC-delta-mediated phosphorylation of Nrf2 serine 40 are both required for stabilization and nuclear translocation of Nrf2 and increased drug resistance. J Cell Sci 122 (2009), 4452–4464.
16. 16 Chanas, S.A., Jiang, Q., McMahon, M., McWalter, G.K., McLellan, L.I., Elcombe, C.R., Henderson, C.J., Wolf, C.R., Moffat, G.J., Itoh, K., Yamamoto, M., Hayes, J.D., Loss of the Nrf2 transcription factor causes a marked reduction in constitutive and inducible expression of the glutathione S-transferase Gsta1, Gsta2, Gstm1, Gstm2, Gstm3 and Gstm4 genes in the livers of male and female mice. Biochem J 365 (2002), 405–416.
17. 17 Thimmulappa, R.K., Mai, K.H., Srisuma, S., Kensler, T.W., Yamamoto, M., Biswal, S., Identification of Nrf2-regulated genes induced by the chemopreventive agent sulforaphane by oligonucleotide microarray. Cancer Res 62 (2002), 5196–5203.
18. 18 Nioi, P., Hayes, J.D., Contribution of NAD(P)H:quinone oxidoreductase 1 to protection against carcinogenesis, and regulation of its gene by the Nrf2 basic-region leucine zipper and the arylhydrocarbon receptor basic helix-loop-helix transcription factors. Mutat Res 555 (2004), 149–171.
19. 19 Alam, J., Wicks, C., Stewart, D., Gong, P., Touchard, C., Otterbein, S., Choi, A.M., Burow, M.E., Tou, J., Mechanism of heme oxygenase-1 gene activation by cadmium in MCF-7 mammary epithelial cells: role of p38 kinase and Nrf2 transcription factor. J Biol Chem 275 (2000), 27694–27702.
20. 20 Chorley, B.N., Campbell, M.R., Wang, X., Karaca, M., Sambandan, D., Bangura, F., Xue, P., Pi, J., Kleeberger, S.R., Bell, D.A., Identification of novel NRF2-regulated genes by ChIP-Seq: influence on retinoid X receptor alpha. Nucleic Acids Res 40 (2012), 7416–7429.
21. 21 Wu, K.C., Cui, J.Y., Klaassen, C.D., Beneficial role of Nrf2 in regulating NADPH generation and consumption. Toxicol Sci 123 (2011), 590–600.
22. 22 Malhotra, D., Portales-Casamar, E., Singh, A., Srivastava, S., Arenillas, D., Happel, C., Shyr, C., Wakabayashi, N., Kensler, T.W., Wasserman, W.W., Biswal, S., Global mapping of binding sites for Nrf2 identifies novel targets in cell survival response through ChIP-Seq profiling and network analysis. Nucleic Acids Res 38 (2010), 5718–5734.
23. 23 Jain, A., Lamark, T., Sjottem, E., Larsen, K.B., Awuh, J.A., Overvatn, A., McMahon, M., Hayes, J.D., Johansen, T., p62/SQSTM1 is a target gene for transcription factor NRF2 and creates a positive feedback loop by inducing antioxidant response element-driven gene transcription. J Biol Chem 285 (2010), 22576–22591.
24. 24 Xu, I.M., Lai, R.K., Lin, S.H., Tse, A.P., Chiu, D.K., Koh, H.Y., Law, C.T., Wong, C.M., Cai, Z., Wong, C.C., Ng, I.O., Transketolase counteracts oxidative stress to drive cancer development. Proc Natl Acad Sci U S A 113 (2016), E725–E734.
25. 25 Zhang, H., Court, N., Forman, H.J., Submicromolar concentrations of 4-hydroxynonenal induce glutamate cysteine ligase expression in HBE1 cells. Redox Rep 12 (2007), 101–106.
26. 26 Ishii, T., Itoh, K., Takahashi, S., Sato, H., Yanagawa, T., Katoh, Y., Bannai, S., Yamamoto, M., Transcription factor Nrf2 coordinately regulates a group of oxidative stress-inducible genes in macrophages. J Biol Chem 275 (2000), 16023–16029.
27. 27 Liu, X., Ward, K., Xavier, C., Jann, J., Clark, A.F., Pang, I.H., Wu, H., The novel triterpenoid RTA 408 protects human retinal pigment epithelial cells against HO-induced cell injury via NF-E2-related factor 2 (Nrf2) activation. Redox Biol 8 (2015), 98–109.
28. 28 Thimmulappa, R.K., Lee, H., Rangasamy, T., Reddy, S.P., Yamamoto, M., Kensler, T.W., Biswal, S., Nrf2 is a critical regulator of the innate immune response and survival during experimental sepsis. J Clin Invest 116 (2006), 984–995.
29. 29 Wardyn Joanna, D., Ponsford Amy, H., Sanderson Christopher, M., Dissecting molecular cross-talk between Nrf2 and NF-κB response pathways. Biochem Soc Trans 43 (2015), 621–626.
30. 30 Li, B., Abdalrahman, A., Lai, Y., Janicki, J.S., Ward, K.W., Meyer, C.J., Wang, X.L., Tang, D., Cui, T., Dihydro-CDDO-trifluoroethyl amide suppresses inflammatory responses in macrophages via activation of Nrf2. Biochem Biophys Res Commun 444 (2014), 555–561.
31. 31 Braun, S., Hanselmann, C., Gassmann, M.G., auf dem Keller, U., Born-Berclaz, C., Chan, K., Kan, Y.W., Werner, S., Nrf2 transcription factor, a novel target of keratinocyte growth factor action which regulates gene expression and inflammation in the healing skin wound. Mol Cell Biol 22 (2002), 5492–5505.
32. 32 Rojo, A.I., McBean, G., Cindric, M., Egea, J., Lopez, M.G., Rada, P., Zarkovic, N., Cuadrado, A., Redox control of microglial function: molecular mechanisms and functional significance. Antioxid Redox Signal 21 (2014), 1766–1801.
33. 33 O'Brien, M.L., Tew, K.D., Glutathione and related enzymes in multidrug resistance. Eur J Cancer 32a (1996), 967–978.
34. 34 Higgins, L.G., Kelleher, M.O., Eggleston, I.M., Itoh, K., Yamamoto, M., Hayes, J.D., Transcription factor Nrf2 mediates an adaptive response to sulforaphane that protects fibroblasts in vitro against the cytotoxic effects of electrophiles, peroxides and redox-cycling agents. Toxicol Appl Pharmacol 237 (2009), 267–280.
35. 35 Pekovic-Vaughan, V., Gibbs, J., Yoshitane, H., Yang, N., Pathiranage, D., Guo, B., Sagami, A., Taguchi, K., Bechtold, D., Loudon, A., Yamamoto, M., Chan, J., van der Horst, G.T., Fukada, Y., Meng, Q.J., The circadian clock regulates rhythmic activation of the NRF2/glutathione-mediated antioxidant defense pathway to modulate pulmonary fibrosis. Genes Dev 28 (2014), 548–560.
36. 36 Xu, Y.Q., Zhang, D., Jin, T., Cai, D.J., Wu, Q., Lu, Y., Liu, J., Klaassen, C.D., Diurnal variation of hepatic antioxidant gene expression in mice. PLoS One, 7, 2012, e44237.
37. 37 Rebrin, I., Kamzalov, S., Sohal, R.S., Effects of age and caloric restriction on glutathione redox state in mice. Free Radic Biol Med 35 (2003), 626–635.
38. 38 Alam, J., Stewart, D., Touchard, C., Boinapally, S., Choi, A.M., Cook, J.L., Nrf2, a Cap‘n'Collar transcription factor, regulates induction of the heme oxygenase-1 gene. J Biol Chem 274 (1999), 26071–26078.
39. 39 Patil, K., Bellner, L., Cullaro, G., Gotlinger, K.H., Dunn, M.W., Schwartzman, M.L., Heme oxygenase-1 induction attenuates corneal inflammation and accelerates wound healing after epithelial injury. Invest Ophthalmol Vis Sci 49 (2008), 3379–3386.
40. 40 Soares, M.P., Seldon, M.P., Gregoire, I.P., Vassilevskaia, T., Berberat, P.O., Yu, J., Tsui, T.Y., Bach, F.H., Heme oxygenase-1 modulates the expression of adhesion molecules associated with endothelial cell activation. J Immunol 172 (2004), 3553–3563.
41. 41 Lin, W., Wu, R.T., Wu, T., Khor, T.O., Wang, H., Kong, A.N., Sulforaphane suppressed LPS-induced inflammation in mouse peritoneal macrophages through Nrf2 dependent pathway. Biochem Pharmacol 76 (2008), 967–973.
42. 42 Reddy, N.M., Potteti, H.R., Mariani, T.J., Biswal, S., Reddy, S.P., Conditional deletion of Nrf2 in airway epithelium exacerbates acute lung injury and impairs the resolution of inflammation. Am J Respir Cell Mol Biol 45 (2011), 1161–1168.
43. 43 Hayes, J.D., Dinkova-Kostova, A.T., The Nrf2 regulatory network provides an interface between redox and intermediary metabolism. Trends Biochem Sci 39 (2014), 199–218.
44. 44 Pickering, A.M., Linder, R.A., Zhang, H., Forman, H.J., Davies, K.J., Nrf2-dependent induction of proteasome and Pa28alphabeta regulator are required for adaptation to oxidative stress. J Biol Chem 287 (2012), 10021–10031.
45. 45 Kwak, M.K., Wakabayashi, N., Greenlaw, J.L., Yamamoto, M., Kensler, T.W., Antioxidants enhance mammalian proteasome expression through the Keap1-Nrf2 signaling pathway. Mol Cell Biol 23 (2003), 8786–8794.
46. 46 Singh, B., Chatterjee, A., Ronghe, A.M., Bhat, N.K., Bhat, H.K., Antioxidant-mediated up-regulation of OGG1 via NRF2 induction is associated with inhibition of oxidative DNA damage in estrogen-induced breast cancer. BMC Cancer, 13, 2013, 253.
47. 47 Holmstrom, K.M., Baird, L., Zhang, Y., Hargreaves, I., Chalasani, A., Land, J.M., Stanyer, L., Yamamoto, M., Dinkova-Kostova, A.T., Abramov, A.Y., Nrf2 impacts cellular bioenergetics by controlling substrate availability for mitochondrial respiration. Biol Open 2 (2013), 761–770.
48. 48 Ludtmann, M.H., Angelova, P.R., Zhang, Y., Abramov, A.Y., Dinkova-Kostova, A.T., Nrf2 affects the efficiency of mitochondrial fatty acid oxidation. Biochem J 457 (2014), 415–424.
49. 49 Richardson, A.G., Schadt, E.E., The role of macromolecular damage in aging and age-related disease. J Gerontol A Biol Sci Med Sci 69 (2014), S28–S32.
50. 50 Finkel, T., Holbrook, N.J., Oxidants, oxidative stress and the biology of ageing. Nature 408 (2000), 239–247.
51. 51 Thannickal, V.J., Fanburg, B.L., Reactive oxygen species in cell signaling. Am J Physiol Lung Cell Mol Physiol 279 (2000), L1005–L1028.
52. 52 Zhang, Y., Ikeno, Y., Qi, W., Chaudhuri, A., Li, Y., Bokov, A., Thorpe, S.R., Baynes, J.W., Epstein, C., Richardson, A., Van Remmen, H., Mice deficient in both Mn superoxide dismutase and glutathione peroxidase-1 have increased oxidative damage and a greater incidence of pathology but no reduction in longevity. J Gerontol A Biol Sci Med Sci 64 (2009), 1212–1220.
53. 53 Perez, V.I., Van Remmen, H., Bokov, A., Epstein, C.J., Vijg, J., Richardson, A., The overexpression of major antioxidant enzymes does not extend the lifespan of mice. Aging Cell 8 (2009), 73–75.
54. 54 Lewis, K.N., Wason, E., Edrey, Y.H., Kristan, D.M., Nevo, E., Buffenstein, R., Regulation of Nrf2 signaling and longevity in naturally long-lived rodents. Proc Natl Acad Sci U S A 112 (2015), 3722–3727.
55. 55 Sykiotis, G.P., Bohmann, D., Keap1/Nrf2 signaling regulates oxidative stress tolerance and lifespan in Drosophila. Dev Cell 14 (2008), 76–85.
56. 56 Tsakiri, E.N., Sykiotis, G.P., Papassideri, I.S., Terpos, E., Dimopoulos, M.A., Gorgoulis, V.G., Bohmann, D., Trougakos, I.P., Proteasome dysfunction in Drosophila signals to an Nrf2-dependent regulatory circuit aiming to restore proteostasis and prevent premature aging. Aging Cell 12 (2013), 802–813.
57. 57 Blackwell, T.K., Steinbaugh, M.J., Hourihan, J.M., Ewald, C.Y., Isik, M., SKN-1/Nrf, stress responses, and aging in Caenorhabditis elegans. Free Radic Biol Med 88 (2015), 290–301.
58. 58 Ewald, C.Y., Landis, J.N., Porter Abate, J., Murphy, C.T., Blackwell, T.K., Dauer-independent insulin/IGF-1-signalling implicates collagen remodelling in longevity. Nature 519 (2015), 97–101.
59. 59 Sykiotis, G.P., Bohmann, D., Stress-activated cap‘n'collar transcription factors in aging and human disease. Sci Signal, 3, 2010, re3.
60. 60 Shih, P.H., Yen, G.C., Differential expressions of antioxidant status in aging rats: the role of transcriptional factor Nrf2 and MAPK signaling pathway. Biogerontology 8 (2007), 71–80.
61. 61 Ungvari, Z., Bailey-Downs, L., Sosnowska, D., Gautam, T., Koncz, P., Losonczy, G., Ballabh, P., de Cabo, R., Sonntag, W.E., Csiszar, A., Vascular oxidative stress in aging: a homeostatic failure due to dysregulation of NRF2-mediated antioxidant response. Am J Physiol Heart Circ Physiol 30 (2011), H363–H372.
62. 62 Suh, J.H., Shenvi, S.V., Dixon, B.M., Liu, H., Jaiswal, A.K., Liu, R.M., Hagen, T.M., Decline in transcriptional activity of Nrf2 causes age-related loss of glutathione synthesis, which is reversible with lipoic acid. Proc Natl Acad Sci U S A 101 (2004), 3381–3386.
63. 63 Kang, M.I., Kobayashi, A., Wakabayashi, N., Kim, S.G., Yamamoto, M., Scaffolding of Keap1 to the actin cytoskeleton controls the function of Nrf2 as key regulator of cytoprotective phase 2 genes. Proc Natl Acad Sci U S A 101 (2004), 2046–2051.
64. 64 Lim, I.K., Won Hong, K., Kwak, I.H., Yoon, G., Park, S.C., Cytoplasmic retention of p-Erk1/2 and nuclear accumulation of actin proteins during cellular senescence in human diploid fibroblasts. Mech Ageing Dev 119 (2000), 113–130.
65. 65 Chen, W., Sun, Z., Wang, X.J., Jiang, T., Huang, Z., Fang, D., Zhang, D.D., Direct interaction between Nrf2 and p21(Cip1/WAF1) upregulates the Nrf2-mediated antioxidant response. Mol Cell 34 (2009), 663–673.
66. 66 Cui, J., Bai, X.Y., Shi, S., Cui, S., Hong, Q., Cai, G., Chen, X., Age-related changes in the function of autophagy in rat kidneys. Age (Dordr) 34 (2012), 329–339.
67. 67 Lau, A., Wang, X.J., Zhao, F., Villeneuve, N.F., Wu, T., Jiang, T., Sun, Z., White, E., Zhang, D.D., A noncanonical mechanism of Nrf2 activation by autophagy deficiency: direct interaction between Keap1 and p62. Mol Cell Biol 30 (2010), 3275–3285.
68. 68 Bartlett, B.J., Isakson, P., Lewerenz, J., Sanchez, H., Kotzebue, R.W., Cumming, R.C., Harris, G.L., Nezis, I.P., Schubert, D.R., Simonsen, A., Finley, K.D., p62, Ref(2)P and ubiquitinated proteins are conserved markers of neuronal aging, aggregate formation and progressive autophagic defects. Autophagy 7 (2011), 572–583.
69. 69 Kawai, Y., Garduno, L., Theodore, M., Yang, J., Arinze, I.J., Acetylation-deacetylation of the transcription factor Nrf2 (nuclear factor erythroid 2-related factor 2) regulates its transcriptional activity and nucleocytoplasmic localization. J Biol Chem 286 (2011), 7629–7640.
70. 70 Sun, Z., Chin, Y.E., Zhang, D.D., Acetylation of Nrf2 by p300/CBP augments promoter-specific DNA binding of Nrf2 during the antioxidant response. Mol Cell Biol 29 (2009), 2658–2672.
71. 71 Hirotsu, Y., Katsuoka, F., Funayama, R., Nagashima, T., Nishida, Y., Nakayama, K., Engel, J.D., Yamamoto, M., Nrf2-MafG heterodimers contribute globally to antioxidant and metabolic networks. Nucleic Acids Res 40 (2012), 10228–10239.
72. 72 Miyamoto, N., Izumi, H., Miyamoto, R., Bin, H., Kondo, H., Tawara, A., Sasaguri, Y., Kohno, K., Transcriptional regulation of activating transcription factor 4 under oxidative stress in retinal pigment epithelial ARPE-19/HPV-16 cells. Invest Ophthalmol Vis Sci 52 (2011), 1226–1234.
73. 73 Mylroie, H., Dumont, O., Bauer, A., Thornton, C.C., Mackey, J., Calay, D., Hamdulay, S.S., Choo, J.R., Boyle, J.J., Samarel, A.M., Randi, A.M., Evans, P.C., Mason, J.C., PKCepsilon-CREB-Nrf2 signalling induces HO-1 in the vascular endothelium and enhances resistance to inflammation and apoptosis. Cardiovasc Res 106 (2015), 509–519.
74. 74 Huang, H.C., Nguyen, T., Pickett, C.B., Regulation of the antioxidant response element by protein kinase C-mediated phosphorylation of NF-E2-related factor 2. Proc Natl Acad Sci U S A 97 (2000), 12475–12480.
75. 75 Numazawa, S., Ishikawa, M., Yoshida, A., Tanaka, S., Yoshida, T., Atypical protein kinase C mediates activation of NF-E2-related factor 2 in response to oxidative stress. Am J Physiol Cell Physiol 285 (2003), C334–C342.
76. 76 Nakaso, K., Yano, H., Fukuhara, Y., Takeshima, T., Wada-Isoe, K., Nakashima, K., PI3K is a key molecule in the Nrf2-mediated regulation of antioxidative proteins by hemin in human neuroblastoma cells. FEBS Lett 546 (2003), 181–184.
77. 77 Zipper, L.M., Mulcahy, R.T., Erk activation is required for Nrf2 nuclear localization during pyrrolidine dithiocarbamate induction of glutamate cysteine ligase modulatory gene expression in HepG2 cells. Toxicol Sci 73 (2003), 124–134.
78. 78 Vari, R., D'Archivio, M., Filesi, C., Carotenuto, S., Scazzocchio, B., Santangelo, C., Giovannini, C., Masella, R., Protocatechuic acid induces antioxidant/detoxifying enzyme expression through JNK-mediated Nrf2 activation in murine macrophages. J Nutr Biochem 22 (2011), 409–417.
79. 79 Jain, A.K., Jaiswal, A.K., GSK-3beta acts upstream of Fyn kinase in regulation of nuclear export and degradation of NF-E2 related factor 2. J Biol Chem 282 (2007), 16502–16510.
80. 80 Facchinetti, M.M., de Boland, A.R., Effect of ageing on the expression of protein kinase C and its activation by 1,25(OH)2-vitamin D3 in rat skeletal muscle. Cell Signal 11 (1999), 39–44.
81. 81 Takahashi, H., Okamura, D., Starr, M.E., Saito, H., Evers, B.M., Age-dependent reduction of the PI3K regulatory subunit p85alpha suppresses pancreatic acinar cell proliferation. Aging Cell 11 (2012), 305–314.
82. 82 Dhakshinamoorthy, S., Jain, A.K., Bloom, D.A., Jaiswal, A.K., Bach1 competes with Nrf2 leading to negative regulation of the antioxidant response element (ARE)-mediated NAD(P)H:quinone oxidoreductase 1 gene expression and induction in response to antioxidants. J Biol Chem 280 (2005), 16891–16900.
83. 83 Shenvi, S.V., Smith, E., Hagen, T.M., Identification of age-specific Nrf2 binding to a novel antioxidant response element locus in the Gclc promoter: a compensatory means for the loss of glutathione synthetic capacity in the aging rat liver?. Aging Cell 11 (2012), 297–304.
84. 84 Rahman, M.M., Sykiotis, G.P., Nishimura, M., Bodmer, R., Bohmann, D., Declining signal dependence of Nrf2-MafS-regulated gene expression correlates with aging phenotypes. Aging Cell 12 (2013), 554–562.
85. 85 He, C.H., Gong, P., Hu, B., Stewart, D., Choi, M.E., Choi, A.M., Alam, J., Identification of activating transcription factor 4 (ATF4) as an Nrf2-interacting protein: implication for heme oxygenase-1 gene regulation. J Biol Chem 276 (2001), 20858–20865.
86. 86 Hussain, S.G., Ramaiah, K.V., Reduced eIF2alpha phosphorylation and increased proapoptotic proteins in aging. Biochem Biophys Res Commun 355 (2007), 365–370.
87. 87 Im, J.Y., Lee, K.W., Woo, J.M., Junn, E., Mouradian, M.M., DJ-1 induces thioredoxin 1 expression through the Nrf2 pathway. Hum Mol Genet 21 (2012), 3013–3024.
88. 88 O'Connell, M.A., Hayes, J.D., The Keap1/Nrf2 pathway in health and disease: from the bench to the clinic. Biochem Soc Trans 43 (2015), 687–689.
89. 89 Wu, T., Zhao, F., Gao, B., Tan, C., Yagishita, N., Nakajima, T., Wong, P.K., Chapman, E., Fang, D., Zhang, D.D., Hrd1 suppresses Nrf2-mediated cellular protection during liver cirrhosis. Genes Dev 28 (2014), 708–722.
90. 90 Rada, P., Rojo, A.I., Chowdhry, S., McMahon, M., Hayes, J.D., Cuadrado, A., SCF/{beta}-TrCP promotes glycogen synthase kinase 3-dependent degradation of the Nrf2 transcription factor in a Keap1-independent manner. Mol Cell Biol 31 (2011), 1121–1133.
91. 91 Liu, X.M., Peyton, K.J., Shebib, A.R., Wang, H., Korthuis, R.J., Durante, W., Activation of AMPK stimulates heme oxygenase-1 gene expression and human endothelial cell survival. Am J Physiol Heart Circ Physiol 300 (2011), H84–H93.
92. 92 Tomasi, M.L., Ryoo, M., Yang, H., Iglesias Ara, A., Ko, K.S., Lu, S.C., Molecular mechanisms of lipopolysaccharide-mediated inhibition of glutathione synthesis in mice. Free Radic Biol Med 68 (2014), 148–158.
93. 93 Narasimhan, M., Patel, D., Vedpathak, D., Rathinam, M., Henderson, G., Mahimainathan, L., Identification of novel microRNAs in post-transcriptional control of Nrf2 expression and redox homeostasis in neuronal, SH-SY5Y cells. PLoS One, 7, 2012, e51111.
94. 94 Zimmermann, K., Baldinger, J., Mayerhofer, B., Atanasov, A.G., Dirsch, V.M., Heiss, E.H., Activated AMPK boosts the Nrf2/HO-1 signaling axis-A role for the unfolded protein response. Free Radic Biol Med 88 (2015), 417–426.
95. 95 Sapir, A., Tsur, A., Koorman, T., Ching, K., Mishra, P., Bardenheier, A., Podolsky, L., Bening-Abu-Shach, U., Boxem, M., Chou, T.F., Broday, L., Sternberg, P.W., Controlled sumoylation of the mevalonate pathway enzyme HMGS-1 regulates metabolism during aging. Proc Natl Acad Sci U S A 111 (2014), E3880–E3889.
96. 96 Gao, Y., Yan, Y., Huang, T., Human age related cataracts: epigenetic suppression of the nuclear factor erythroid 2 related factor 2 mediated antioxidant system. Mol Med Rep 11 (2015), 1442–1447.
97. 97 Inukai, S., Slack, F., MicroRNAs and the genetic network in aging. J Mol Biol 425 (2013), 3601–3608.
98. 98 Yang, J.J., Tao, H., Hu, W., Liu, L.P., Shi, K.H., Deng, Z.Y., Li, J., MicroRNA-200a controls Nrf2 activation by target Keap1 in hepatic stellate cell proliferation and fibrosis. Cell Signal 26 (2014), 2381–2389.
99. 99 Yu, S., Khor, T.O., Cheung, K.L., Li, W., Wu, T.Y., Huang, Y., Foster, B.A., Kan, Y.W., Kong, A.N., Nrf2 expression is regulated by epigenetic mechanisms in prostate cancer of TRAMP mice. PLoS One, 5, 2010, e8579.
100. 100 Belden, W.J., Dunlap, J.C., Aging well with a little wine and a good clock. Cell 153 (2013), 1421–1422.
101. 101 Rockey, D.C., Bell, P.D., Hill, J.A., Fibrosis: a common pathway to organ injury and failure. N Engl J Med 372 (2015), 1138–1149.
102. 102 Thannickal, V.J., Zhou, Y., Gaggar, A., Duncan, S.R., Fibrosis: ultimate and proximate causes. J Clin Invest 124 (2014), 4673–4677.
103. 103 Thannickal, V.J., Toews, G.B., White, E.S., Lynch, J.P. 3rd, Martinez, F.J., Mechanisms of pulmonary fibrosis. Annu Rev Med 55 (2004), 395–417.
104. 104 Thannickal, V.J., Mechanistic links between aging and lung fibrosis. Biogerontology 14 (2013), 609–615.
105. 105 Raghu, G., Weycker, D., Edelsberg, J., Bradford, W.Z., Oster, G., Incidence and prevalence of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 174 (2006), 810–816.
106. 106 Schwartz, D.A., Helmers, R.A., Galvin, J.R., Van Fossen, D.S., Frees, K.L., Dayton, C.S., Burmeister, L.F., Hunninghake, G.W., Determinants of survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 149 (1994), 450–454.
107. 107 Border, W.A., Noble, N.A., Transforming growth factor beta in tissue fibrosis. N Engl J Med 331 (1994), 1286–1292.
108. 108 Tomasek, J.J., Gabbiani, G., Hinz, B., Chaponnier, C., Brown, R.A., Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol 3 (2002), 349–363.
109. 109 Hecker, L., Vittal, R., Jones, T., Jagirdar, R., Luckhardt, T.R., Horowitz, J.C., Pennathur, S., Martinez, F.J., Thannickal, V.J., NADPH oxidase-4 mediates myofibroblast activation and fibrogenic responses to lung injury. Nat Med 15 (2009), 1077–1081.
110. 110 Jiang, J.X., Chen, X., Serizawa, N., Szyndralewiez, C., Page, P., Schroder, K., Brandes, R.P., Devaraj, S., Torok, N.J., Liver fibrosis and hepatocyte apoptosis are attenuated by GKT137831, a novel NOX4/NOX1 inhibitor in vivo. Free Radic Biol Med 53 (2012), 289–296.
111. 111 Bondi, C.D., Manickam, N., Lee, D.Y., Block, K., Gorin, Y., Abboud, H.E., Barnes, J.L., NAD(P)H oxidase mediates TGF-beta1-induced activation of kidney myofibroblasts. J Am Soc Nephrol 21 (2010), 93–102.
112. 112 Kuroda, J., Ago, T., Matsushima, S., Zhai, P., Schneider, M.D., Sadoshima, J., NADPH oxidase 4 (Nox4) is a major source of oxidative stress in the failing heart. Proc Natl Acad Sci U S A 107 (2010), 15565–15570.
113. 113 Cho, H.Y., Reddy, S.P., Yamamoto, M., Kleeberger, S.R., The transcription factor NRF2 protects against pulmonary fibrosis. FASEB J 18 (2004), 1258–1260.
114. 114 Cho, H.Y., Reddy, S.P., Kleeberger, S.R., Nrf2 defends the lung from oxidative stress. Antioxid Redox Signal 8 (2006), 76–87.
115. 115 Cho, H.Y., Reddy, S.P., Debiase, A., Yamamoto, M., Kleeberger, S.R., Gene expression profiling of NRF2-mediated protection against oxidative injury. Free Radic Biol Med 38 (2005), 325–343.
116. 116 Artaud-Macari, E., Goven, D., Brayer, S., Hamimi, A., Besnard, V., Marchal-Somme, J., Ali, Z.E., Crestani, B., Kerdine-Romer, S., Boutten, A., Bonay, M., Nuclear factor erythroid 2-related factor 2 nuclear translocation induces myofibroblastic dedifferentiation in idiopathic pulmonary fibrosis. Antioxid Redox Signal 18 (2013), 66–79.
117. 117 Martinez, F.J., de Andrade, J.A., Anstrom, K.J., King, T.E. Jr., Raghu, G., Randomized trial of acetylcysteine in idiopathic pulmonary fibrosis. N Engl J Med 370 (2014), 2093–2101.
118. 118 Sussan, T.E., Rangasamy, T., Blake, D.J., Malhotra, D., El-Haddad, H., Bedja, D., Yates, M.S., Kombairaju, P., Yamamoto, M., Liby, K.T., Sporn, M.B., Gabrielson, K.L., Champion, H.C., Tuder, R.M., Kensler, T.W., Biswal, S., Targeting Nrf2 with the triterpenoid CDDO-imidazolide attenuates cigarette smoke-induced emphysema and cardiac dysfunction in mice. Proc Natl Acad Sci U S A 106 (2009), 250–255.
119. 119 Tarozzi, A., Angeloni, C., Malaguti, M., Morroni, F., Hrelia, S., Hrelia, P., Sulforaphane as a potential protective phytochemical against neurodegenerative diseases. Oxid Med Cell Longev, 2013, 2013, 415078.
120. 120 Hecker, L., Jagirdar, R., Jin, T., Thannickal, V.J., Reversible differentiation of myofibroblasts by MyoD. Exp Cell Res 317 (2011), 1914–1921.
121. 121 Ungvari, Z., Bagi, Z., Feher, A., Recchia, F.A., Sonntag, W.E., Pearson, K., de Cabo, R., Csiszar, A., Resveratrol confers endothelial protection via activation of the antioxidant transcription factor Nrf2. Am J Physiol Heart Circ Physiol 299 (2010), H18–H24.
122. 122 He, X., Wang, L., Szklarz, G., Bi, Y., Ma, Q., Resveratrol inhibits paraquat-induced oxidative stress and fibrogenic response by activating the nuclear factor erythroid 2-related factor 2 pathway. J Pharmacol Exp Ther 342 (2012), 81–90.
123. 123 Tapia, E., Soto, V., Ortiz-Vega, K.M., Zarco-Marquez, G., Molina-Jijon, E., Cristobal-Garcia, M., Santamaria, J., Garcia-Nino, W.R., Correa, F., Zazueta, C., Pedraza-Chaverri, J., Curcumin induces Nrf2 nuclear translocation and prevents glomerular hypertension, hyperfiltration, oxidant stress, and the decrease in antioxidant enzymes in 5/6 nephrectomized rats. Oxid Med Cell Longev, 2012, 2012, 269039.
124. 124 Lee, J.C., Kinniry, P.A., Arguiri, E., Serota, M., Kanterakis, S., Chatterjee, S., Solomides, C.C., Javvadi, P., Koumenis, C., Cengel, K.A., Christofidou-Solomidou, M., Dietary curcumin increases antioxidant defenses in lung, ameliorates radiation-induced pulmonary fibrosis, and improves survival in mice. Radiat Res 173 (2010), 590–601.
125. 125 Tanigawa, S., Fujii, M., Hou, D.X., Action of Nrf2 and Keap1 in ARE-mediated NQO1 expression by quercetin. Free Radic Biol Med 42 (2007), 1690–1703.
126. 126 Yao, P., Nussler, A., Liu, L., Hao, L., Song, F., Schirmeier, A., Nussler, N., Quercetin protects human hepatocytes from ethanol-derived oxidative stress by inducing heme oxygenase-1 via the MAPK/Nrf2 pathways. J Hepatol 47 (2007), 253–261.
127. 127 Nakamura, T., Matsushima, M., Hayashi, Y., Shibasaki, M., Imaizumi, K., Hashimoto, N., Shimokata, K., Hasegawa, Y., Kawabe, T., Attenuation of transforming growth factor-beta-stimulated collagen production in fibroblasts by quercetin-induced heme oxygenase-1. Am J Respir Cell Mol Biol 44 (2011), 614–620.
128. 128 Lin, S.X., Lisi, L., Dello Russo, C., Polak, P.E., Sharp, A., Weinberg, G., Kalinin, S., Feinstein, D.L., The anti-inflammatory effects of dimethyl fumarate in astrocytes involve glutathione and haem oxygenase-1. ASN Neuro, 3, 2011, e00055.
129. 129 Thimmulappa, R.K., Rangasamy, T., Alam, J., Biswal, S., Dibenzoylmethane activates Nrf2-dependent detoxification pathway and inhibits benzo(a)pyrene induced DNA adducts in lungs. Med Chem 4 (2008), 473–481.
130. 130 Tan, S.M., Sharma, A., Stefanovic, N., Yuen, D.Y., Karagiannis, T.C., Meyer, C., Ward, K.W., Cooper, M.E., de Haan, J.B., Derivative of bardoxolone methyl, dh404, in an inverse dose-dependent manner lessens diabetes-associated atherosclerosis and improves diabetic kidney disease. Diabetes 63 (2014), 3091–3103.
131. 131 de Zeeuw, D., Akizawa, T., Audhya, P., Bakris, G.L., Chin, M., Christ-Schmidt, H., Goldsberry, A., Houser, M., Krauth, M., Lambers Heerspink, H.J., McMurray, J.J., Meyer, C.J., Parving, H.H., Remuzzi, G., Toto, R.D., Vaziri, N.D., Wanner, C., Wittes, J., Wrolstad, D., Chertow, G.M., Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease. N Engl J Med 369 (2013), 2492–2503.
132. 132 Wang, X.J., Sun, Z., Villeneuve, N.F., Zhang, S., Zhao, F., Li, Y., Chen, W., Yi, X., Zheng, W., Wondrak, G.T., Wong, P.K., Zhang, D.D., Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2. Carcinogenesis 29 (2008), 1235–1243.
133. 133 Satoh, H., Moriguchi, T., Takai, J., Ebina, M., Yamamoto, M., Nrf2 prevents initiation but accelerates progression through the Kras signaling pathway during lung carcinogenesis. Cancer Res 73 (2013), 4158–4168.
134. 134 Bauer, A.K., Cho, H.Y., Miller-Degraff, L., Walker, C., Helms, K., Fostel, J., Yamamoto, M., Kleeberger, S.R., Targeted deletion of Nrf2 reduces urethane-induced lung tumor development in mice. PLoS One, 6, 2011, e26590.
135. 135 Ren, D., Villeneuve, N.F., Jiang, T., Wu, T., Lau, A., Toppin, H.A., Zhang, D.D., Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism. Proc Natl Acad Sci U S A 108 (2011), 1433–1438.